Chinese consensus on prevention of colorectal neoplasia (2021, Shanghai). Issue 2 (3rd March 2022)

• Record Type: Journal Article
• Is Part Of: Journal of digestive diseases. Volume 23:Issue 2(2022)
• Page Start: 58
• Page End: 90
• Publication Date: 2022-03-03
• Subjects: adenoma -- colorectal neoplasms -- environmental exposure -- genetic factors -- tertiary prevention; Digestive organs -- Diseases -- Periodicals; Gastroenterology -- Periodicals; 616.3
• DOI: 10.1111/1751-2980.13079
• Languages: English
• ISSNs: 1751-2972

Abstract

Abstract : Most patients with colorectal cancer (CRC) were diagnosed in advanced stage and the prognosis is poor. Therefore, early detection and prevention of CRC are very important. As with other cancers, there is also the tertiary prevention for CRC. The primary prevention is etiological prevention, which is mainly the treatment of adenoma or inflammation for preventing the development into cancer. The secondary prevention is the early diagnosis and early treatment for avoiding progressing to advanced cancer. The tertiary prevention belongs to the broad category of prevention, mainly for advanced CRC, through surgical treatment and postoperative adjuvant chemotherapy, radiotherapy, targeted therapy, immunotherapy for preventing tumor recurrence or metastasis. This consensus is based on the recent domestic and international consensus guidelines and the latest progress of international researches in the past five years. This consensus opinion seminar was hosted by the Chinese Society of Gastroenterology and Cancer Collaboration Group of Chinese Society of Gastroenterology, and was organized by the Division of Gastroenterology and Hepatology & Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University. The consensus opinion contains 60 statement clauses, the standard and basis of the evidence‐based medicine grade and voting grade of the statement strictly complied with the relevant international regulations and practice.